What is mycoplasma pneumonia?
Mycoplasma pneumonia is a lower respiratory tract infection caused by Mycoplasma pneumonia. It mainly manifests as cough and fever. It is easy to occur in crowded environments and can be spread through droplets and direct contact.
What are the triggering factors for mycoplasma pneumonia?
People with malnutrition and low immune function are prone to the disease
Patients recovering from respiratory diseases are prone to the disease
Closed spaces with dense crowds and poor air circulation can increase the incidence of disease
Typical symptoms of mycoplasma pneumonia?
After the human body is infected with Mycoplasma pneumonia, it will generally experience an incubation period of 1-3 weeks before relevant symptoms appear and gradually worsen within 2-4 days.
The most typical symptoms of mycoplasma pneumonia in children are fever and cough
The initial stage of cough is paroxysmal, irritating dry cough
As the disease progresses, coughing and sputum production may occur, and some children with severe symptoms may develop wheezing, difficulty breathing, etc.
Infection with Mycoplasma pneumonia does not necessarily lead to pneumonia
Mycoplasma pneumonia may occur only if Mycoplasma pneumonia invades the lower respiratory tract.
How to treat infection with Mycoplasma pneumonia?
Mycoplasma pneumonia is self-limiting; most patients with mild symptoms can recover without treatment. However, since mycoplasma does not have a cell wall structure, penicillin and cephalosporin drugs, most commonly used to fight bacterial infections in daily life, cannot play their role.
Macrolides, tetracyclines, and peaknordone antibiotics can be taken orally first for mild infections. However, it should be noted that children under 8 years old should not use tetracycline antibiotics, and minors under 18 years old should not use menordone. antibiotic-like
For severe infection, you can choose intravenous medication, usually azithromycin or erythromycin, and change it after the condition improves. For oral medications;
Regardless of whether the disease is mild or severe, treatment must be carried out under the guidance of a doctor, and blind use of medication must be avoided
Home care and prevention
Ensure adequate rest and energy intake, and ensure water and electrolyte balance
Pay attention to ventilation and keep clean. Children with allergies should avoid contact with tobacco, pets, flowers, etc.
Mycoplasma pneumonia has no cell wall structure and can be killed by 75% alcohol and chlorine-containing disinfectants (such as 84 disinfectant) Reduce crowd gatherings and wear masks when going out
Moderate exercise, physical fitness, regular work and rest, and a balanced diet
The role of probiotics in children with mycoplasma pneumonia
Although antibiotics are an effective method to treat mycoplasma pneumonia, the use of antibiotics can cause an imbalance of intestinal flora homeostasis, leading to adverse reactions such as antibiotic-associated diarrhea (AAD) in patients. Mouse experiments have shown that probiotic strains that produce short-chain fatty acids, such as Bifidobacterium infantis and Clostridium butyricum, can restore the intestinal microbiota and reduce systemic inflammation in AAD mice. A clinical trial involving 55 children with mycoplasma pneumonia led by the First Affiliated Hospital of Zhejiang University School of Medicine also proved that the use of a mixed agent of Clostridium butyricum and Bifidobacterium infantis can effectively prevent azithromycin-induced pneumonia. AAD.
The compound probiotics reconstructed the intestinal flora to a certain extent, restored the diversity of the bacterial flora, significantly enhanced the barrier function of the intestinal mucosa, and reduced the systemic inflammatory response in children. Therefore, it can have a good auxiliary treatment effect. In addition, probiotics also stimulate the immune system through the lung-gut axis and have a good regulatory effect on lung diseases caused by a variety of pathogenic microorganisms.
